We only have this paper's title and publication details.
Read it at the sourceEvaluates the combined impact of fecal microbiota transplantation and infliximab on gut health in patients with refractory inflammatory bowel disease, suggesting potential therapeutic...
This study is registered with ClinicalTrials.gov as NCT07149441.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: